Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...

Ansa is accepting orders for synthetic DNA constructs ranging from 7.5 kb up to 50 kb for various applications.

We talk about news in cancer, updates on COVID's origin, and business news in biotech in this episode of Touching Base.

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...

Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly ...

Researchers expect LICONN technology will be broadly useful to enable high-resolution tissue analysis in other organs and ...

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already ...

Single-cell biology has transformed how we decode cellular heterogeneity, but a new frontier is emerging: understanding what ...